APO Research
Talk to an analyst

APO RESEARCH · REPORT

Remdesivir

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Remdesivir Market Analysis and Forecast 2026-2032

2 January 2026199 pages

Choose your research edition.

Industry ResearchRemdesivir Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Remdesivir Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Remdesivir Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Remdesivir Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Remdesivir Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Remdesivir market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Remdesivir is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Remdesivir is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Remdesivir is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Remdesivir is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Remdesivir include Kelun Pharma, Hunan Warrant Pharmaceutical, Hainan Haiyao, Bright Gene and Gilead Sciences, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Remdesivir, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Remdesivir, also provides the sales of main regions and countries. Of the upcoming market potential for Remdesivir, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Remdesivir sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Remdesivir market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Remdesivir sales, projected growth trends, production technology, application and end-user industry.

Remdesivir Segment by Company

Kelun Pharma

Hunan Warrant Pharmaceutical

Hainan Haiyao

Bright Gene

Gilead Sciences

Remdesivir Segment by Type

10 mM*1 mL in DMSO

100mg

10mg

50mg

5mg

Remdesivir Segment by Application

Drug Store

Hospital

Clinics

Others

Remdesivir Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Remdesivir market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Remdesivir and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Remdesivir.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Remdesivir in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Remdesivir manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Remdesivir sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Remdesivir Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 10 mM*1 mL in DMSO Major Manufacturers Table 3. 100mg Major Manufacturers Table 4. 10mg Major Manufacturers Table 5. 50mg Major Manufacturers Table 6. 5mg Major Manufacturers Table 7. Global Remdesivir Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Drug Store Major Manufacturers Table 9. Hospital Major Manufacturers Table 10. Clinics Major Manufacturers Table 11. Others Major Manufacturers Table 12. Remdesivir Industry Trends Table 13. Remdesivir Industry Drivers Table 14. Remdesivir Industry Opportunities and Challenges Table 15. Remdesivir Industry Restraints Table 16. Global Remdesivir Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Remdesivir Revenue by Region (2021-2026) & (US$ Million) Table 18. Global Remdesivir Revenue by Region (2027-2032) & (US$ Million) Table 19. Global Remdesivir Revenue Market Share by Region (2021-2026) Table 20. Global Remdesivir Revenue Market Share by Region (2027-2032) Table 21. Global Remdesivir Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 22. Global Remdesivir Sales by Region (2021-2026) & (K Units) Table 23. Global Remdesivir Sales by Region (2027-2032) & (K Units) Table 24. Global Remdesivir Sales Market Share by Region (2021-2026) Table 25. Global Remdesivir Sales Market Share by Region (2027-2032) Table 26. Global Remdesivir Revenue by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Remdesivir Revenue Market Share by Manufacturers (2021-2026) Table 28. Global Remdesivir Sales by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Remdesivir Sales Market Share by Manufacturers (2021-2026) Table 30. Global Remdesivir Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 31. Global Remdesivir Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 32. Global Remdesivir Key Manufacturers Manufacturing Sites & Headquarters Table 33. Global Remdesivir Manufacturers, Product Type & Application Table 34. Global Remdesivir Manufacturers' Establishment Date Table 35. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 36. Global Remdesivir by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 37. Global Remdesivir Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Remdesivir Revenue by Type (2021-2026) & (US$ Million) Table 39. Global Remdesivir Revenue by Type (2027-2032) & (US$ Million) Table 40. Global Remdesivir Revenue Market Share by Type (2021-2026) Table 41. Global Remdesivir Revenue Market Share by Type (2027-2032) Table 42. Global Remdesivir Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 43. Global Remdesivir Sales by Type (2021-2026) & (K Units) Table 44. Global Remdesivir Sales by Type (2027-2032) & (K Units) Table 45. Global Remdesivir Sales Market Share by Type (2021-2026) Table 46. Global Remdesivir Sales Market Share by Type (2027-2032) Table 47. Global Remdesivir Price by Type (2021-2026) & (US$/Unit) Table 48. Global Remdesivir Price by Type (2027-2032) & (US$/Unit) Table 49. Global Remdesivir Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Remdesivir Revenue by Application (2021-2026) & (US$ Million) Table 51. Global Remdesivir Revenue by Application (2027-2032) & (US$ Million) Table 52. Global Remdesivir Revenue Market Share by Application (2021-2026) Table 53. Global Remdesivir Revenue Market Share by Application (2027-2032) Table 54. Global Remdesivir Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 55. Global Remdesivir Sales by Application (2021-2026) & (K Units) Table 56. Global Remdesivir Sales by Application (2027-2032) & (K Units) Table 57. Global Remdesivir Sales Market Share by Application (2021-2026) Table 58. Global Remdesivir Sales Market Share by Application (2027-2032) Table 59. Global Remdesivir Price by Application (2021-2026) & (US$/Unit) Table 60. Global Remdesivir Price by Application (2027-2032) & (US$/Unit) Table 61. Kelun Pharma Company Information Table 62. Kelun Pharma Business Overview Table 63. Kelun Pharma Remdesivir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Kelun Pharma Remdesivir Product Portfolio Table 65. Kelun Pharma Recent Development Table 66. Hunan Warrant Pharmaceutical Company Information Table 67. Hunan Warrant Pharmaceutical Business Overview Table 68. Hunan Warrant Pharmaceutical Remdesivir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Hunan Warrant Pharmaceutical Remdesivir Product Portfolio Table 70. Hunan Warrant Pharmaceutical Recent Development Table 71. Hainan Haiyao Company Information Table 72. Hainan Haiyao Business Overview Table 73. Hainan Haiyao Remdesivir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Hainan Haiyao Remdesivir Product Portfolio Table 75. Hainan Haiyao Recent Development Table 76. Bright Gene Company Information Table 77. Bright Gene Business Overview Table 78. Bright Gene Remdesivir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Bright Gene Remdesivir Product Portfolio Table 80. Bright Gene Recent Development Table 81. Gilead Sciences Company Information Table 82. Gilead Sciences Business Overview Table 83. Gilead Sciences Remdesivir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Gilead Sciences Remdesivir Product Portfolio Table 85. Gilead Sciences Recent Development Table 86. North America Remdesivir Revenue by Type (2021-2026) & (US$ Million) Table 87. North America Remdesivir Revenue by Type (2027-2032) & (US$ Million) Table 88. North America Remdesivir Sales by Type (2021-2026) & (K Units) Table 89. North America Remdesivir Sales by Type (2027-2032) & (K Units) Table 90. North America Remdesivir Sales Price by Type (2021-2026) & (US$/Unit) Table 91. North America Remdesivir Sales Price by Type (2027-2032) & (US$/Unit) Table 92. North America Remdesivir Revenue by Application (2021-2026) & (US$ Million) Table 93. North America Remdesivir Revenue by Application (2027-2032) & (US$ Million) Table 94. North America Remdesivir Sales by Application (2021-2026) & (K Units) Table 95. North America Remdesivir Sales by Application (2027-2032) & (K Units) Table 96. North America Remdesivir Sales Price by Application (2021-2026) & (US$/Unit) Table 97. North America Remdesivir Sales Price by Application (2027-2032) & (US$/Unit) Table 98. North America Remdesivir Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. North America Remdesivir Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 100. North America Remdesivir Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 101. North America Remdesivir Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 102. North America Remdesivir Sales by Country (2021-2026) & (K Units) Table 103. North America Remdesivir Sales by Country (2027-2032) & (K Units) Table 104. North America Remdesivir Sales Price by Country (2021-2026) & (US$/Unit) Table 105. North America Remdesivir Sales Price by Country (2027-2032) & (US$/Unit) Table 106. United States Remdesivir Revenue (2021-2032) & (US$ Million) Table 107. Canada Remdesivir Revenue (2021-2032) & (US$ Million) Table 108. Europe Remdesivir Revenue by Type (2021-2026) & (US$ Million) Table 109. Europe Remdesivir Revenue by Type (2027-2032) & (US$ Million) Table 110. Europe Remdesivir Sales by Type (2021-2026) & (K Units) Table 111. Europe Remdesivir Sales by Type (2027-2032) & (K Units) Table 112. Europe Remdesivir Sales Price by Type (2021-2026) & (US$/Unit) Table 113. Europe Remdesivir Sales Price by Type (2027-2032) & (US$/Unit) Table 114. Europe Remdesivir Revenue by Application (2021-2026) & (US$ Million) Table 115. Europe Remdesivir Revenue by Application (2027-2032) & (US$ Million) Table 116. Europe Remdesivir Sales by Application (2021-2026) & (K Units) Table 117. Europe Remdesivir Sales by Application (2027-2032) & (K Units) Table 118. Europe Remdesivir Sales Price by Application (2021-2026) & (US$/Unit) Table 119. Europe Remdesivir Sales Price by Application (2027-2032) & (US$/Unit) Table 120. Europe Remdesivir Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. Europe Remdesivir Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 122. Europe Remdesivir Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 123. Europe Remdesivir Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 124. Europe Remdesivir Sales by Country (2021-2026) & (K Units) Table 125. Europe Remdesivir Sales by Country (2027-2032) & (K Units) Table 126. Europe Remdesivir Sales Price by Country (2021-2026) & (US$/Unit) Table 127. Europe Remdesivir Sales Price by Country (2027-2032) & (US$/Unit) Table 128. Germany Remdesivir Revenue (2021-2032) & (US$ Million) Table 129. France Remdesivir Revenue (2021-2032) & (US$ Million) Table 130. U.K. Remdesivir Revenue (2021-2032) & (US$ Million) Table 131. Italy Remdesivir Revenue (2021-2032) & (US$ Million) Table 132. Netherlands Remdesivir Revenue (2021-2032) & (US$ Million) Table 133. Nordic Countries Remdesivir Revenue (2021-2032) & (US$ Million) Table 134. China Remdesivir Revenue by Type (2021-2026) & (US$ Million) Table 135. China Remdesivir Revenue by Type (2027-2032) & (US$ Million) Table 136. China Remdesivir Sales by Type (2021-2026) & (K Units) Table 137. China Remdesivir Sales by Type (2027-2032) & (K Units) Table 138. China Remdesivir Sales Price by Type (2021-2026) & (US$/Unit) Table 139. China Remdesivir Sales Price by Type (2027-2032) & (US$/Unit) Table 140. China Remdesivir Revenue by Application (2021-2026) & (US$ Million) Table 141. China Remdesivir Revenue by Application (2027-2032) & (US$ Million) Table 142. China Remdesivir Sales by Application (2021-2026) & (K Units) Table 143. China Remdesivir Sales by Application (2027-2032) & (K Units) Table 144. China Remdesivir Sales Price by Application (2021-2026) & (US$/Unit) Table 145. China Remdesivir Sales Price by Application (2027-2032) & (US$/Unit) Table 146. Asia Remdesivir Revenue by Type (2021-2026) & (US$ Million) Table 147. Asia Remdesivir Revenue by Type (2027-2032) & (US$ Million) Table 148. Asia Remdesivir Sales by Type (2021-2026) & (K Units) Table 149. Asia Remdesivir Sales by Type (2027-2032) & (K Units) Table 150. Asia Remdesivir Sales Price by Type (2021-2026) & (US$/Unit) Table 151. Asia Remdesivir Sales Price by Type (2027-2032) & (US$/Unit) Table 152. Asia Remdesivir Revenue by Application (2021-2026) & (US$ Million) Table 153. Asia Remdesivir Revenue by Application (2027-2032) & (US$ Million) Table 154. Asia Remdesivir Sales by Application (2021-2026) & (K Units) Table 155. Asia Remdesivir Sales by Application (2027-2032) & (K Units) Table 156. Asia Remdesivir Sales Price by Application (2021-2026) & (US$/Unit) Table 157. Asia Remdesivir Sales Price by Application (2027-2032) & (US$/Unit) Table 158. Asia Remdesivir Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. Asia Remdesivir Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 160. Asia Remdesivir Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 161. Asia Remdesivir Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 162. Asia Remdesivir Sales by Country (2021-2026) & (K Units) Table 163. Asia Remdesivir Sales by Country (2027-2032) & (K Units) Table 164. Asia Remdesivir Sales Price by Country (2021-2026) & (US$/Unit) Table 165. Asia Remdesivir Sales Price by Country (2027-2032) & (US$/Unit) Table 166. Japan Remdesivir Revenue (2021-2032) & (US$ Million) Table 167. South Korea Remdesivir Revenue (2021-2032) & (US$ Million) Table 168. India Remdesivir Revenue (2021-2032) & (US$ Million) Table 169. Australia Remdesivir Revenue (2021-2032) & (US$ Million) Table 170. China Taiwan Remdesivir Revenue (2021-2032) & (US$ Million) Table 171. Southeast Asia Remdesivir Revenue (2021-2032) & (US$ Million) Table 172. SAMEA Remdesivir Revenue by Type (2021-2026) & (US$ Million) Table 173. SAMEA Remdesivir Revenue by Type (2027-2032) & (US$ Million) Table 174. SAMEA Remdesivir Sales by Type (2021-2026) & (K Units) Table 175. SAMEA Remdesivir Sales by Type (2027-2032) & (K Units) Table 176. SAMEA Remdesivir Sales Price by Type (2021-2026) & (US$/Unit) Table 177. SAMEA Remdesivir Sales Price by Type (2027-2032) & (US$/Unit) Table 178. SAMEA Remdesivir Revenue by Application (2021-2026) & (US$ Million) Table 179. SAMEA Remdesivir Revenue by Application (2027-2032) & (US$ Million) Table 180. SAMEA Remdesivir Sales by Application (2021-2026) & (K Units) Table 181. SAMEA Remdesivir Sales by Application (2027-2032) & (K Units) Table 182. SAMEA Remdesivir Sales Price by Application (2021-2026) & (US$/Unit) Table 183. SAMEA Remdesivir Sales Price by Application (2027-2032) & (US$/Unit) Table 184. SAMEA Remdesivir Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 185. SAMEA Remdesivir Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 186. SAMEA Remdesivir Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 187. SAMEA Remdesivir Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 188. SAMEA Remdesivir Sales by Country (2021-2026) & (K Units) Table 189. SAMEA Remdesivir Sales by Country (2027-2032) & (K Units) Table 190. SAMEA Remdesivir Sales Price by Country (2021-2026) & (US$/Unit) Table 191. SAMEA Remdesivir Sales Price by Country (2027-2032) & (US$/Unit) Table 192. Brazil Remdesivir Revenue (2021-2032) & (US$ Million) Table 193. Argentina Remdesivir Revenue (2021-2032) & (US$ Million) Table 194. Chile Remdesivir Revenue (2021-2032) & (US$ Million) Table 195. Colombia Remdesivir Revenue (2021-2032) & (US$ Million) Table 196. Peru Remdesivir Revenue (2021-2032) & (US$ Million) Table 197. Saudi Arabia Remdesivir Revenue (2021-2032) & (US$ Million) Table 198. Israel Remdesivir Revenue (2021-2032) & (US$ Million) Table 199. UAE Remdesivir Revenue (2021-2032) & (US$ Million) Table 200. Turkey Remdesivir Revenue (2021-2032) & (US$ Million) Table 201. Iran Remdesivir Revenue (2021-2032) & (US$ Million) Table 202. Egypt Remdesivir Revenue (2021-2032) & (US$ Million) Table 203. Key Raw Materials Table 204. Raw Materials Key Suppliers Table 205. Remdesivir Distributors List Table 206. Remdesivir Customers List Table 207. Research Programs/Design for This Report Table 208. Authors List of This Report Table 209. Secondary Sources Table 210. Primary Sources List of Figures Figure 1. Remdesivir Image Figure 2. Global Remdesivir Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Remdesivir Market Size Share 2021 VS 2025 VS 2032 Figure 4. 10 mM*1 mL in DMSO Image Figure 5. 100mg Image Figure 6. 10mg Image Figure 7. 50mg Image Figure 8. 5mg Image Figure 9. Global Remdesivir Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Remdesivir Market Size Share 2021 VS 2025 VS 2032 Figure 11. Drug Store Image Figure 12. Hospital Image Figure 13. Clinics Image Figure 14. Others Image Figure 15. Global Remdesivir Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Remdesivir Revenue (2021-2032) & (US$ Million) Figure 17. Global Remdesivir Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Remdesivir Revenue Market Share by Region: 2025 Versus 2032 Figure 19. Global Remdesivir Revenue Market Share by Region (2021-2032) Figure 20. Global Remdesivir Sales (2021-2032) & (K Units) Figure 21. Global Remdesivir Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 22. Global Remdesivir Sales Market Share by Region (2021-2032) Figure 23. US & Canada & Mexico Remdesivir Sales YoY (2021-2032) & (K Units) Figure 24. Europe Remdesivir Sales YoY (2021-2032) & (K Units) Figure 25. China Remdesivir Sales YoY (2021-2032) & (K Units) Figure 26. Asia (Excluding China) Remdesivir Sales YoY (2021-2032) & (K Units) Figure 27. South America, Middle East and Africa Remdesivir Sales YoY (2021-2032) & (K Units) Figure 28. Global Remdesivir Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 29. Global Remdesivir Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 30. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Global Remdesivir Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 32. Global Remdesivir Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Remdesivir Revenue Market Share by Type (2021-2032) Figure 34. Global Remdesivir Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 35. Global Remdesivir Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 36. Global Remdesivir Sales Market Share by Type (2021-2032) Figure 37. Global Remdesivir Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 38. Global Remdesivir Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Remdesivir Revenue Market Share by Application (2021-2032) Figure 40. Global Remdesivir Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 41. Global Remdesivir Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 42. Global Remdesivir Sales Market Share by Application (2021-2032) Figure 43. North America Remdesivir Revenue Share by Type (2021-2032) Figure 44. North America Remdesivir Sales Share by Type (2021-2032) Figure 45. North America Remdesivir Revenue Share by Application (2021-2032) Figure 46. North America Remdesivir Sales Share by Application (2021-2032) Figure 47. North America Remdesivir Revenue Share by Country (2021-2032) Figure 48. North America Remdesivir Sales Share by Country (2021-2032) Figure 49. Europe Remdesivir Revenue Share by Type (2021-2032) Figure 50. Europe Remdesivir Sales Share by Type (2021-2032) Figure 51. Europe Remdesivir Revenue Share by Application (2021-2032) Figure 52. Europe Remdesivir Sales Share by Application (2021-2032) Figure 53. Europe Remdesivir Revenue Share by Country (2021-2032) Figure 54. Europe Remdesivir Sales Share by Country (2021-2032) Figure 55. China Remdesivir Revenue Share by Type (2021-2032) Figure 56. China Remdesivir Sales Share by Type (2021-2032) Figure 57. China Remdesivir Revenue Share by Application (2021-2032) Figure 58. China Remdesivir Sales Share by Application (2021-2032) Figure 59. Asia Remdesivir Revenue Share by Type (2021-2032) Figure 60. Asia Remdesivir Sales Share by Type (2021-2032) Figure 61. Asia Remdesivir Revenue Share by Application (2021-2032) Figure 62. Asia Remdesivir Sales Share by Application (2021-2032) Figure 63. Asia Remdesivir Revenue Share by Country (2021-2032) Figure 64. Asia Remdesivir Sales Share by Country (2021-2032) Figure 65. SAMEA Remdesivir Revenue Share by Type (2021-2032) Figure 66. SAMEA Remdesivir Sales Share by Type (2021-2032) Figure 67. SAMEA Remdesivir Revenue Share by Application (2021-2032) Figure 68. SAMEA Remdesivir Sales Share by Application (2021-2032) Figure 69. SAMEA Remdesivir Revenue Share by Country (2021-2032) Figure 70. SAMEA Remdesivir Sales Share by Country (2021-2032) Figure 71. Remdesivir Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Remdesivir Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • 10 mM*1 mL in DMSO
  • 100mg
  • 10mg
  • 50mg
  • 5mg
Applications
  • Drug Store
  • Hospital
  • Clinics
  • Others
Companies covered
  • Kelun Pharma
  • Hunan Warrant Pharmaceutical
  • Hainan Haiyao
  • Bright Gene
  • Gilead Sciences

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Remdesivir Market by Type
  3. 1.2.1 Global Remdesivir Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 10 mM*1 mL in DMSO
  5. 1.2.3 100mg
  6. 1.2.4 10mg
  7. 1.2.5 50mg
  8. 1.2.6 5mg
  9. 1.3 Remdesivir Market by Application
  10. 1.3.1 Global Remdesivir Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Drug Store
  12. 1.3.3 Hospital
  13. 1.3.4 Clinics
  14. 1.3.5 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Remdesivir Market Dynamics
  1. 2.1 Remdesivir Industry Trends
  2. 2.2 Remdesivir Industry Drivers
  3. 2.3 Remdesivir Industry Opportunities and Challenges
  4. 2.4 Remdesivir Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Remdesivir Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Remdesivir Revenue by Region
  3. 3.2.1 Global Remdesivir Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Remdesivir Revenue by Region (2021-2026)
  5. 3.2.3 Global Remdesivir Revenue by Region (2027-2032)
  6. 3.2.4 Global Remdesivir Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Remdesivir Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Remdesivir Sales by Region
  9. 3.4.1 Global Remdesivir Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Remdesivir Sales by Region (2021-2026)
  11. 3.4.3 Global Remdesivir Sales by Region (2027-2032)
  12. 3.4.4 Global Remdesivir Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Remdesivir Revenue by Manufacturers
  2. 4.1.1 Global Remdesivir Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Remdesivir Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Remdesivir Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Remdesivir Sales by Manufacturers
  6. 4.2.1 Global Remdesivir Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Remdesivir Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Remdesivir Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Remdesivir Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Remdesivir Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Remdesivir Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Remdesivir Manufacturers, Product Type & Application
  13. 4.7 Global Remdesivir Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Remdesivir Market CR5 and HHI
  16. 4.8.2 2025 Remdesivir Tier 1, Tier 2, and Tier 3
5 Remdesivir Market by Type
  1. 5.1 Global Remdesivir Revenue by Type
  2. 5.1.1 Global Remdesivir Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Remdesivir Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Remdesivir Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Remdesivir Sales by Type
  6. 5.2.1 Global Remdesivir Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Remdesivir Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Remdesivir Sales Market Share by Type (2021-2032)
  9. 5.3 Global Remdesivir Price by Type
6 Remdesivir Market by Application
  1. 6.1 Global Remdesivir Revenue by Application
  2. 6.1.1 Global Remdesivir Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Remdesivir Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Remdesivir Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Remdesivir Sales by Application
  6. 6.2.1 Global Remdesivir Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Remdesivir Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Remdesivir Sales Market Share by Application (2021-2032)
  9. 6.3 Global Remdesivir Price by Application
7 Company Profiles
  1. 7.1 Kelun Pharma
  2. 7.1.1 Kelun Pharma Company Information
  3. 7.1.2 Kelun Pharma Business Overview
  4. 7.1.3 Kelun Pharma Remdesivir Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Kelun Pharma Remdesivir Product Portfolio
  6. 7.1.5 Kelun Pharma Recent Developments
  7. 7.2 Hunan Warrant Pharmaceutical
  8. 7.2.1 Hunan Warrant Pharmaceutical Company Information
  9. 7.2.2 Hunan Warrant Pharmaceutical Business Overview
  10. 7.2.3 Hunan Warrant Pharmaceutical Remdesivir Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Hunan Warrant Pharmaceutical Remdesivir Product Portfolio
  12. 7.2.5 Hunan Warrant Pharmaceutical Recent Developments
  13. 7.3 Hainan Haiyao
  14. 7.3.1 Hainan Haiyao Company Information
  15. 7.3.2 Hainan Haiyao Business Overview
  16. 7.3.3 Hainan Haiyao Remdesivir Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Hainan Haiyao Remdesivir Product Portfolio
  18. 7.3.5 Hainan Haiyao Recent Developments
  19. 7.4 Bright Gene
  20. 7.4.1 Bright Gene Company Information
  21. 7.4.2 Bright Gene Business Overview
  22. 7.4.3 Bright Gene Remdesivir Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Bright Gene Remdesivir Product Portfolio
  24. 7.4.5 Bright Gene Recent Developments
  25. 7.5 Gilead Sciences
  26. 7.5.1 Gilead Sciences Company Information
  27. 7.5.2 Gilead Sciences Business Overview
  28. 7.5.3 Gilead Sciences Remdesivir Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Gilead Sciences Remdesivir Product Portfolio
  30. 7.5.5 Gilead Sciences Recent Developments
8 North America
  1. 8.1 North America Remdesivir Market Size by Type
  2. 8.1.1 North America Remdesivir Revenue by Type (2021-2032)
  3. 8.1.2 North America Remdesivir Sales by Type (2021-2032)
  4. 8.1.3 North America Remdesivir Price by Type (2021-2032)
  5. 8.2 North America Remdesivir Market Size by Application
  6. 8.2.1 North America Remdesivir Revenue by Application (2021-2032)
  7. 8.2.2 North America Remdesivir Sales by Application (2021-2032)
  8. 8.2.3 North America Remdesivir Price by Application (2021-2032)
  9. 8.3 North America Remdesivir Market Size by Country
  10. 8.3.1 North America Remdesivir Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Remdesivir Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Remdesivir Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Remdesivir Market Size by Type
  2. 9.1.1 Europe Remdesivir Revenue by Type (2021-2032)
  3. 9.1.2 Europe Remdesivir Sales by Type (2021-2032)
  4. 9.1.3 Europe Remdesivir Price by Type (2021-2032)
  5. 9.2 Europe Remdesivir Market Size by Application
  6. 9.2.1 Europe Remdesivir Revenue by Application (2021-2032)
  7. 9.2.2 Europe Remdesivir Sales by Application (2021-2032)
  8. 9.2.3 Europe Remdesivir Price by Application (2021-2032)
  9. 9.3 Europe Remdesivir Market Size by Country
  10. 9.3.1 Europe Remdesivir Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Remdesivir Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Remdesivir Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Remdesivir Market Size by Type
  2. 10.1.1 China Remdesivir Revenue by Type (2021-2032)
  3. 10.1.2 China Remdesivir Sales by Type (2021-2032)
  4. 10.1.3 China Remdesivir Price by Type (2021-2032)
  5. 10.2 China Remdesivir Market Size by Application
  6. 10.2.1 China Remdesivir Revenue by Application (2021-2032)
  7. 10.2.2 China Remdesivir Sales by Application (2021-2032)
  8. 10.2.3 China Remdesivir Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Remdesivir Market Size by Type
  2. 11.1.1 Asia Remdesivir Revenue by Type (2021-2032)
  3. 11.1.2 Asia Remdesivir Sales by Type (2021-2032)
  4. 11.1.3 Asia Remdesivir Price by Type (2021-2032)
  5. 11.2 Asia Remdesivir Market Size by Application
  6. 11.2.1 Asia Remdesivir Revenue by Application (2021-2032)
  7. 11.2.2 Asia Remdesivir Sales by Application (2021-2032)
  8. 11.2.3 Asia Remdesivir Price by Application (2021-2032)
  9. 11.3 Asia Remdesivir Market Size by Country
  10. 11.3.1 Asia Remdesivir Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Remdesivir Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Remdesivir Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Remdesivir Market Size by Type
  2. 12.1.1 SAMEA Remdesivir Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Remdesivir Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Remdesivir Price by Type (2021-2032)
  5. 12.2 SAMEA Remdesivir Market Size by Application
  6. 12.2.1 SAMEA Remdesivir Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Remdesivir Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Remdesivir Price by Application (2021-2032)
  9. 12.3 SAMEA Remdesivir Market Size by Country
  10. 12.3.1 SAMEA Remdesivir Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Remdesivir Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Remdesivir Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Remdesivir Value Chain Analysis
  2. 13.1.1 Remdesivir Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Remdesivir Production Mode & Process
  6. 13.2 Remdesivir Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Remdesivir Distributors
  9. 13.2.3 Remdesivir Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst